Ikarian Capital »

Icosavax shares owned by Ikarian Capital

Quarter-by-quarter ownership of Icosavax shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Icosavax

Tip: Access up to 7 years of quarterly data

All positions including Icosavax held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Icosavax by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.9M 440k 15.76

More positions owned by Ikarian Capital

Argenx Se Sponsored Adr (ARGX)
Krystal Biotech Call Option (KRYS)
Cytokinetics Com New (CYTK)
Alnylam Pharmaceuticals Call Option (ALNY)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Crispr Therapeutics Namen Akt (CRSP)
Eli Lilly & Co. Put Option (LLY)
Sarepta Therapeutics (SRPT)
Prothena Corp SHS Call Option (PRTA)
Amylyx Pharmaceuticals (AMLX)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Crinetics Pharmaceuticals In (CRNX)
Soleno Therapeutics (SLNO)
Eyepoint Pharmaceuticals Com New (EYPT)

View all positions for Ikarian Capital

Top funds holding Icosavax

RA Capital Management
Qiming U.S. Ventures Management
Pentwater Capital Management
Vanguard Group
Alpine Associates Management
Laurion Capital Management
Segantii Capital Management
TIG Advisors
Marshall Wace
CSS
Citigroup
Ikarian Capital
Logos Global Management
Goldman Sachs Group
Citadel Advisors

View all funds holding Icosavax